Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

CAP-Ketamine for Antidepressant Resistant PTSD

To see complete record on, please visit this link

Id: NCT02655692

Organisation Name: VA Office of Research and Development

Overal Status: Completed

Start Date: April 18, 2016

Last Update: June 2, 2022

Lead Sponsor: VA Office of Research and Development

Brief Summary: The purpose of this study is to test the safety and efficacy of repeated doses of ketamine as compared to placebo, in reducing symptoms of Posttraumatic Stress Disorder (PTSD) in an active duty military and Veteran population.

  • PTSD
  • Posttraumatic Stress Disorder

Total execution time in seconds: 0.57320380210876